Adrenal cortical carcinoma: Advances in the pathophysiology and management of this malignancy;Le corticosurrénalome: Progrès dans la Physiopathologie et la prise en charge d'un cancer rare

Bulletin de l'Academie Nationale de Medecine

Volumn 192, Issue 1, 2008, Pages 87-103

  Bertagna, Xavier ^a   Groussin, Lionel ^a   Libe, Rossella ^a   Bertherat, Jérôme ^a  

^a Institut Cochin   (France)

Author keywords

Adrenal cortex neoplasms; Biological; Genetics; Prognosis; Tumor markers

Indexed keywords

ADRENAL CORTEX TUMOR; CANCER STAGING; CARCINOMA; GENETICS; HUMAN; PROGNOSIS; REVIEW;

ADRENAL CORTEX NEOPLASMS; CARCINOMA; HUMANS; NEOPLASM STAGING; PROGNOSIS;

EID: 54049134901     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)32870-5     Document Type: Article

References (29)

1. [1] LUTON J.P., CERDAS S., BILLAUD L., et al. -Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N. Engl. J. Med., 1990, 322(17), 1195-1201 (Pubitemid 20137851)
2. ALLOLIO B., HAHNER S., WEISMANN D., FASSNACHT M. -Management of adrenocortical carcinoma. Clin. Endocrinol. (Oxf), 2004, 60, 273-287
3. [3] SCHTEINGART D.E., DOHERTY G.M., GAUGER P.G. et al. -Management of patients with adrenal cancer : recommendations of an international consensus conference. Endocr. Relat. Cancer, 2005, 12(3), 667-680 (Pubitemid 41483000)
4. [4] LIBE R., BERTHERAT J. -Molecular genetics of adrenocortical tumours, from familial to sporadic diseases. Eur. J. Endocrinol, 2005, 153(4), 477-487 (Pubitemid 41568145)
5. [5] ABIVEN G., COSTE J., GROUSSIN L. et al. -Clinical and biological features in the prognosis of adrenocortical cancer : poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. J. Clin. Endocrinol. Metab., 2006, 91(1), 2650-2655 (Pubitemid 44024632)
6. [6] WAJCHENBERG B.L., ALBERGARIA PEREIRA M.A., MEDONCA B.B. et al. -Adrenocortical carcinoma : clinical and laboratory observations. Cancer, 2000, 88(4), 711-736 (Pubitemid 30091090)
7. [7] LUTON J.P., MARTINEZ M., COSTE J., BERTHERAT J. -Outcome in patients with adrenal incidentaloma selected for surgery : an analysis of 88 cases investigated in a single clinical center. TiMi-. J. Endocrinol, 2000, 143(1), 111-117 (Pubitemid 30482208)
8. [8] BOLAND G.W., LEE M.J., GAZELLE G.S., HALPERN E.F., MCNICHOLAS M.M., MUELLER P.R. - Characterization of adrenal masses using unenhanced CT : an analysis of the literature. Am. J. Roentgenol.,1998, 171(1), 201-204 (Pubitemid 28308675)
9. BECHERER A., VIERHAPPER H., POTZI C et al. -FDG-PET in adrenocortical carcinoma. Cancer Biother Radiopharm., 2001, 16(4), 289-295
10. TENENBAUM F., GROUSSIN L., FOEHRENBACH H., et al. -18F-fluorodeoxyglucose positron emission tomography as a diagnostic tool for malignancy of adrenocortical tumours ? Preliminary results in 13 consecutive patients. Eur. J. Endocrinol., 2004150(6), 789-792
11. LEBOULLEUX S., DROMAIN C., BONNIAUD G., et al. -Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma : a prospective comparison with computed tomography. J. Clin. Endocrinol. Metab., 2005, Dec 20, (epub ahead of print).
12. [12] WEISS L.M. -Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am. J. Surg. Pathol., 1984, 8(3), 163-169 (Pubitemid 14166767)
13. [13] GICQUEL C., BERTHERAT J., LE BOUC Y., BERTAGNA X. -Pathogenesis of adrenocortical incidentalomas and genetic syndromes associated with adrenocortical neoplasms. Endocrinol. Metab. Clin. North Am., 2000, 29(1), 1-13. (Pubitemid 30151885)
14. [14] GICQUEL C., BERTAGNA X., GASTON V. et al. -Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. Cancer Res., 2001, W(18), 6762-6767 (Pubitemid 32896498)
15. MAC FARLANE D.A. -Cancer of the adrenal cortex : the natural history, prognosis and treatment in the study of 58 cases. Ann. Royal Coll. Surg, 1958, 109, 613-618.
16. [16] ICARD P., GOUDET P., CHARPENAY C. et al. -Adrenocortical carcinomas : surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J. Surg., 2001, 25(7), 891-897 (Pubitemid 32666390)
17. [17] ASSIE G., ANTONI G., TISSIER F. et al. -Prognostic parameters of metastatic adrenocortical carcinoma. J. Clin. Endocrinol. Metab., 2007, 92(1), 148-154 (Pubitemid 46067523)
18. [18] BERTHERAT J., GROUSSIN L., BERTAGNA X. -Mechanisms of disease : adrenocortical tumorsmolecular advances and clinical perspectives. Nat. Clin. Pract. Endocrinol. Metab., 2006,2(11), 632-641 (Pubitemid 44691299)
19. DE BAERE T. -Local treatment of adrenal cortical carcinoma metastases with interventional radiology techniques. In Adrenal Cancer, Ed. X. Bertagna, John Libbey Eurotext 2006, pp : 97-106.
20. [20] BERRUTI A., TERZOLO M., SPERONE P. et al. -Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma : a large prospective phase II trial. Endocr. Relat. Cancer, 2005, 12(3), 657-666 (Pubitemid 41482999)
21. [21] VAN SLOOTEN H., MOOLENAAR A.J., VAN SETERS A.P., SMEENK D. -The treatment of adrenocortical carcinoma with o,p'-DDD : prognostic implications of serum level monitoring. Eur. J. Cancer Clin. Oncol., 1984, 20(1), 47-53. (Pubitemid 14224356)
22. [22] BAUDIN E, PELLEGRITI G, BONNAY M, et al. -Impact of monitoring plasma 1,1dichlorodiphenildichloroethane (o,p'DDD) levels on the treatment of patients with adrenocortical carcinoma. Cancer, 2001, 92(6), 1385-1392 (Pubitemid 32947821)
23. [24] DE FRAIPONT F., EL ATIFI M., CHERRADI N. et al. -Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic Acid microarrays identifies several candidate genes as markers of malignancy. J. Clin. Endocrinol. Metab., 2005, 90(3), 1819-1829 (Pubitemid 40464057)
24. [25] GIORDANO T.J., THOMAS D.G., KUICK R. et al. -Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. Am. J. Pathol., 2003 162(2), 521-531 (Pubitemid 36267859)
25. [26] KIRSCHNER L.S. -Emerging treatment strategies for adrenocortical carcinoma : a new hope. J. Clin. Endocrinol. Metab., 2006, 91(1), 14-21 (epub 2005 Oct 18). (Pubitemid 43069108)
26. [27] TISSIER F., CAVARD C., GROUSSIN L. et al. -Mutations of beta-catenin in adrenocortical tumors : activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Res., 2005, 05(17), 7622-7627 (Pubitemid 41297234)
27. [28] TERZOLO M., ANGELÍ A., FASSNACHT et al. -Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl. J. Med., 2007, 356(23), 2372-2380 (Pubitemid 46883771)
28. GOLDWASSER F. and BERTAGNA X. -Chemotherapy for adrenal cortical cancer in Adrenal Cancer, Ed. X. Bertagna, John Libbey Eurotext 2006, pp : 59-70.
29. BERTHERAT J., COSTE J., BERTAGNA X. -Adjuvant mitotane in adrenocortical carcinoma. N Engl. J. Med., 2007,357(12),1256-1257